Chemours vs Solstice Advanced Materials
CC and SOLS side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CC and SOLS compare
Solstice Advanced Materials is the larger company, worth 4.7 times as much as Chemours ($9.6B against $2.0B).
Solstice Advanced Materials grew revenue faster over the last twelve months (9.2% versus −0.92% for Chemours).
Solstice Advanced Materials keeps more of each dollar of sales as profit, with a net margin of 5.1% compared with −5.2% at Chemours.
Both pay dividends: Chemours yields 2.6% and Solstice Advanced Materials 0.37%.
Solstice Advanced Materials scores higher on the StockData Score (7 against 6 for Chemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CC | SOLS |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $9.6B |
| Share price | $13.53 | $60.55 |
| Change, 1 year | −1.7% | 22.9% |
| Change, 5 years | −58.4% | – |
| Beta (5Y) | 1.56 | – |
| Employees | 5,700 | 4,100 |
| StockData Score | ||
| Total score | 6 | 7 (better) |
| Valuation score | 2 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 1 | 2 (better) |
| Dividend score | 2 (better) | 1 |
| Valuation | ||
| P/S | 0.4× (better) | 2.3× |
| P/B | – | 6.1× |
| EV/EBITDA | 9.7× | – |
| P/FCF | 9.3× (better) | 49.3× |
| FCF yield | 10.7% (better) | 2.0% |
| Fair value | – | $33.30 |
| Margin of safety | – | −81.8% |
| Growth | ||
| Revenue growth (TTM) | −0.92% | 9.2% (better) |
| Revenue growth, 5Y average | 3.2% | – |
| Net income growth (TTM) | – | −59.3% |
| Profitability | ||
| Gross margin | 15.3% | 30.6% (better) |
| Net margin | −5.2% | 5.1% (better) |
| FCF margin | 3.8% | 4.8% (better) |
| Return on equity | −340% | 8.7% (better) |
| Financial health | ||
| Debt / equity | – | 1.24 |
| Net debt / EBITDA | 5.92 | – |
| Current ratio | 1.66 (better) | 1.46 |
| Altman Z-score | 1.36 | 2.24 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.6% (better) | 0.37% |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | −12.5% | – |
| Shareholder yield | 2.6% (better) | 0.37% |
| Ownership | ||
| Held by institutions | 90.2% | 84.4% |
| Held by insiders | 0.96% | 0.04% |
| Insider net buying, 12 months | $489K | – |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 10.3% | 3.2% |
Go deeper
- CC stock overview
- CC income statement
- CC valuation and score
- SOLS stock overview
- SOLS income statement
- SOLS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.